2017-03-21,Tenax Therapeutics Announces Year-End 2016 Financial Results And Provides Corporate Update
2017-03-15,Tenax Therapeutics To Discuss Year-End 2016 Financial Results And Provide Business Update
2017-02-02,These 5 Stocks Under $10 Could Light Up Soon
2017-01-31,Tenax Therapeutics Announces Top-Line Results From Phase 3 LEVO-CTS Trial In Cardiac Surgery
2016-11-18,Tenax Therapeutics Announces Completion Of Enrollment For Phase 3 LEVO-CTS Trial In Cardiac Surgery
2016-11-10,Tenax Therapeutics Announces Third Quarter 2016 Financial Results And Provides Corporate Update
2016-11-03,Tenax Therapeutics To Discuss Third Quarter 2016 Financial Results And Provide Business Update
2016-10-05,Tenax Therapeutics Provides Clinical Update For Lead Candidate Levosimendan
2016-08-11,Tenax Therapeutics Announces Second Quarter 2016 Financial Results And Provides Corporate Update
2016-08-03,Tenax Therapeutics To Discuss Second Quarter 2016 Financial Results And Provide Business Update
2016-05-19,Tenax Therapeutics Announces First Quarter 2016 Financial Results And Provides Corporate Update
2016-05-10,Â Tenax Therapeutics To Discuss First Quarter 2016 Financial Results And Provide Business Update
2016-03-16,Tenax Therapeutics Announces 2015 Transitional Report And Provides Corporate Update
2016-03-09,Tenax Therapeutics To Provide 2015 Transitional Report And Business Update
2016-03-01,Tenax Therapeutics To Present At Cowen And Company 36th Annual Health Care Conference
2016-02-04,Tenax Therapeutics To Present At Leerink Partners 5th Annual Global Healthcare Conference
2016-02-01,Tenax Therapeutics Provides Update of Phase 3 LEVO-CTS Trial for LCOS
2015-12-22,Tenax Therapeutics Highlights Completion Of Enrollment For LeoPARDS Trial By Imperial College London
2015-12-15,Tenax Therapeutics Announces Second Quarter Fiscal Year 2016 Financial Results
2015-12-08,Tenax Therapeutics To Provide Corporate Update And Discuss Second Quarter Fiscal Year 2016 Financial Results On December 15, 2015
2015-10-08,Tenax Therapeutics Provides Clinical Update For Lead Candidate Levosimendan
2015-09-22,Tenax Therapeutics To Present At Ladenburg Thalmann 2015 Healthcare Conference
2015-09-14,Tenax Therapeutics Announces First Quarter Fiscal Year 2016 Financial Results
2015-09-10,Tenax Therapeutics Partners With Sepsis Alliance To Raise Awareness Of Sepsis And Septic Shock
2015-09-08,Tenax Therapeutics To Provide Corporate Update And Discuss First Quarter Fiscal Year 2016 Financial Results On September 14, 2015
2015-08-18,Tenax Therapeutics Announces Nomination Of James Mitchum To Board Of Directors
2015-08-05,Tenax Therapeutics To Present At 2015 Wedbush PacGrow Healthcare Conference
2015-07-16,Tenax Therapeutics Announces Fourth Quarter And Fiscal Year 2015 Financial Results
2015-07-09,Tenax Therapeutics To Provide Corporate Update And Discuss Fourth Quarter And Fiscal Year 2015 Financial Results On July 16, 2015
2015-07-01,Tenax Therapeutics Spotlights Academic Publication On Levosimendan In Cardiac Surgery
2015-06-16,Tenax Therapeutics Highlights New Scientific Publication Regarding The Potential Mortality Benefits Of Levosimendan In Septic Shock Patients
2015-04-15,Tenax Therapeutics Provides Clinical And Corporate Update
2015-03-31,Tenax Therapeutics Announces Analyst Day And Webcast On April 13, 2015
2015-03-18,Tenax Therapeutics Announces Third Quarter Fiscal Year 2015 Financial Results
2015-03-11,Tenax Therapeutics To Provide Corporate Update And Discuss Third Quarter Fiscal Year 2015 Financial Results On March 18, 2015
2015-03-05,Tenax Therapeutics Highlights Recent Scientific Publications On Levosimendan
2015-02-23,Tenax Therapeutics To Present At Cowen & Company 35th Annual Health Care Conference
2015-02-20,Tenax Therapeutics Issues Employment Inducement Award With Appointment Of Paula Bokesch, M.D., As Chief Medical Officer
2015-02-03,Tenax Therapeutics Announces Appointment Of Paula Bokesch, M.D., As Chief Medical Officer
2014-12-17,Tenax Therapeutics Announces Second Quarter Fiscal Year 2015 Financial Results
2014-12-10,Tenax Therapeutics To Provide Corporate Update And Discuss Second Quarter Fiscal Year 2015 Financial Results On December 17, 2014
2014-11-25,Small Cap IR Issues Tenax Therapeutics Analyst Report: Large Validated Market Opportunity Inspires $12 Price Target
2014-09-24,Tenax Therapeutics Announces First Quarter Fiscal Year 2015 Financial Results
2014-09-22,Tenax Therapeutics Announces First Patients Enrolled In Phase 3 LEVO-CTS Clinical Trial Of Levosimendan
2014-09-19,Tenax Therapeutics To Provide Corporate Update And Discuss First Quarter Fiscal Year 2015 Financial Results On September 24, 2014
,
,
,
,
